FDA indication

Amitriptyline

Depression

Aripiprazole

- bipolar

- schizophrenia

- depression, adjunctive with antidepressant

- Tourette syndrome

- irritability with autistic disorder

Bupropion

- depression

- season affective disorder (SAD)

- smoking cessation assistance

Buspirone

anxiety

Citalopram

Depression

Desvenlafaxine

Depression

Escitalopram

- depression

- GAD

Fluoxetine

- bipolar major depression

- MDD

- OCD

- panic disorder

- premenstrual dysphoric disorder

- bulimia nervosa

Hydroxyzine (HCl + pamoate)

- anxiety

- pruritis

- sedation

Lithium carbonate

bipolar maintenance/manic episode

Lurasidone

- depressive episodes associated with bipolar disorder

- schizophrenia

Mirtazapine

Depression

Nortriptyline

- chronic pain

- diabetic neuropathy

Olanzapine

- bipolar, acute mixed or manic episodes, maintenance

- schizophrenia

- depression

Paroxetine

- depression

- GAD

- SAD

- OCD

- panic disorder

- PTSD

- premenstrual syndrome

- vasomotor symptoms of menopause

Quetiapine

- bipolar disorder or schizophrenia, therapy initiation/maintenance

- major depressive disorder, adjunct to antidepressants

Risperidone

- autistic disorder, irritability

- acute manic or mixed episodes of bipolar I disorder

- schizophrenia

Sertraline

- depression

- OCD

- panic disorder, PTSD, social phobia disorder

- premenstrual dysphoric disorder

Trazodone

MDD

Venlafaxine

- GAD

- depression

- panic disorder

- social anxiety disorder

Lamotrigine

- bipolar I

- partial seizure, adjunct or monotherapy, tonic-clonic, LGS

Benztropine

- extrapyramidal disease, medication-induced movement disorder (EPS)

- parkinsonism